US Environmental Protection Agency
Office of Pesticide Programs

Office of Pesticide Programs

Microbiology Laboratory

Environmental Science Center, Ft. Meade, MD

Quantitative Method for Testing Antimicrobial
Agents Against Spores of C. difficile on Hard, Non-
porous Surfaces

SOP Number: MB-31-07

Date Revised: 09-22-22


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page i of 18

SOP Number

MB-31-07

Title

Quantitative Method for Testing Antimicrobial Agents Against
Spores of C. difficile on Hard, Non-porous Surfaces

Revisions Made

•	Minor editorial changes for clarification purposes.

•	Added language in carriers section; the top of the carrier is
brushed; only the top is visually screened and inoculated (Section
11.4.a).

•	When preparing mucin, it is now passed through a 0.2 |im pore
diameter membrane filter instead of autoclaved (Section 11.2.1 .iii).

•	Footnotes changed from referencing ASTM E3218-19 to ASTM
E3218-21.

•	Removed Attachment 3: Gravimetric and Physical Wetness
Determination for Towelettes from SOP and put it into the
guidance.

•	Updated ASTM International Standard reference from 2019 to
2021 and updated version number from E3218-19 to E3218-21.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 1 of 18

SOP Number

MB-31-07

Title

Quantitative Method for Testing Antimicrobial Agents Against
Spores of C. difficile on Hard, Non-porous Surfaces

Scope

This document describes a standardized approach to quantitatively
determine the effectiveness of antimicrobial chemicals in treating
hard, non-porous surfaces contaminated with spores of
Clostridioides difficile (ATCC 43598) based on ASTM E3218-21.

Application

The test method was designed to determine the logics reduction (LR)
in spores on a hard, non-porous surface after exposure to a test
chemical in a closed system.





Approval Date

SOP Developer

/^ut- 09/20/22

Print Name: Lisa Smith

SOP Reviewer

09/20/22

Print Name: Rebecca Pines

Quality Assurance Unit

/W\Jju 09/20/22

Print Name: Michele Cottrill

Branch Chief

09/20/22

Print Name: Rebecca Pines



Data SOP issued:

09/20/22

Controlled copy number:

0

Date SOP withdrawn:




-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 2 of 18

TABLE OF CONTENTS

Contents	Page Number

1.

DEFINITIONS

3

2.

HEALTH AND SAFETY

3

3.

PERSONNEL QUALIFICATIONS AND TRAINING

3

4.

INSTRUMENT CALIBRATION

3

5.

SAMPLE HANDLING AND STORAGE

3

6.

QUALITY CONTROL

3

7.

INTERFERENCES

3

8. NON-CONFORMING DATA

3

9.

DATA MANAGEMENT

4

10.

CAUTIONS

4

11.

SPECIAL APPARATUS AND MATERIALS

4

12.

PROCEDURE AND ANALYSIS

6

13.

DATA ANALYSIS/CALCULATIONS

13

14.

FORMS AND DATA SHEETS

14

15.

REFERENCES

14


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 3 of 18

1. Definitions

Additional abbreviations/definitions are provided in the text.

1.	Frozen spore suspension = a preparation of bacterial endospores that is
maintained at -80±5°C and have been prepared and qualified in
accordance with SOP MB-28. Spore suspensions of C. difficile used in this
test method may be stored for up to 90 days under the conditions provided
in the definition.

2.	Final test suspension = thawed frozen spore suspension including the
addition of a soil load.

3.	Test system control = a solution of 1,500±150 ppm laboratory grade
sodium hypochlorite (NaOCl) used to validate each efficacy test.

2. Health and
Safety

Follow procedures specified in SOP MB-01, Laboratory Biosafety. The Study
Director and/or lead analyst should consult the Safety Data Sheet for specific
hazards associated with the test substance.

3. Personnel
Qualifications
and Training

1.	A reference standard (e.g., predetermined concentrations of sodium
hypochlorite) may be used to check method performance and analyst
proficiency.

2.	Refer to SOP ADM-04, OPP Microbiology Laboratory Training.

4. Instrument
Calibration

Refer to SOP EQ-01 (pH meters), EQ-02 (thermometers and hygrometers),
EQ-03 (weigh balances), EQ-05 (timers) and QC-19 (pipettes) for details on
method and frequency of calibration.

5. Sample

Handling and
Storage

Refer to SOP MB-22; Preparation and Sampling Procedures for Antimicrobial
Test Substances, and SOP COC-01; Chain of Custody.

6. Quality Control

For quality control purposes, the required information is documented on the
appropriate form(s) (see section 14).

7. Interferences

1.	Verify the neutralizer specified for the disinfectant test chemical in
advance of efficacy testing. See Attachment 2.

2.	Clostridioides difficile (ATCC 43598), formerly known as Clostridium
difficile, is an obligate anaerobe and must be incubated under strict
anaerobic conditions. C. difficile will not grow in the presence of oxygen.
Verification of anaerobic conditions is required.

3.	During testing, do not process a carrier where the test substance runs off
the carrier; replace with an untreated inoculated carrier and vial.

8. Non-
conforming
Data

1. For an acceptable test, the logio density (LD) for each control carrier
should be 6.0-7.0 spores/carrier.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 4 of 18



2. The 1,500 ppm NaOCl test system control should exhibit an LR of <3.0 in
spores using a contact period of 3 min±3 s.

9. Data

Management

Archive the data consistent with SOP ADM-03, Records and Archives.

10. Cautions

Avoid extended soaking of the carriers in water or detergent and prolonged
rinsing to reduce risk of corrosion or rusting.

11. Special

Apparatus and
Materials

1.	Test microbe. C. difficile (ATCC 43598); spores prepared according to
SOP MB-28.

2.	Recovery medium. Brain-heart infusion agar with yeast extract, horse
blood and sodium taurocholate (BHIY-HT). For enumeration of spores,
commercially available as pre-reduced (Anaerobe Systems, Morgan Hill,
CA, or equivalent).

3.	Reagents

a.	Water. Either de-ionized water or water with equivalent quality for
making reagent solutions and culture media.

b.	Phosphate buffered saline (PBS). For use as a rinsing agent and to
prepare PBS containing 0.1% (v/v) Tween-80 (PBS-T) and PBS-T
with 0.1% (w/v) sodium thiosulfate; adjust pH to 7.0±0.5 if
necessary.

c.	PBS containing 0.1% (v/v) Tween 80 (PBS-T). Diluting reagent;
adjust pH to 7.2±0.2 if necessary.

d.	PBS-T with 0.1% (w/v) sodium thiosulfate. Neutralizer for the test
system control (1,500±150 ppm NaOCl); adjust pH to 7.2±0.2 if
necessary.

i. Confirm the effectiveness of PBS-T with 0.1% (w/v) sodium
thiosulfate as a neutralizer for 1,500±150 ppm NaOCl using
the procedure in Attachment 2.

e.	Neutralizer. Specific to disinfectant test chemical being evaluated as
determined for effectiveness and toxicity according to Attachment 2.
Use a neutralizer containing 0.1% (v/v) Tween-80 to reduce spore
clumping.

f.	Soil load. The standard soil load to be incorporated in the qualified
spore suspension is a mixture of the following stock solutions:

i. Bovine serum albumin (BSA): Add 0.5 g BSA (radio

immunoassay [RIA] grade or equivalent) to 10 mL of PBS,
mix, and pass through a 0.2 jam pore diameter membrane


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 5 of 18

filter to sterilize.

ii.	Yeast extract: Add 0.5 g yeast extract to 10 mL of PBS, mix,
and pass through a 0.2 |im pore diameter membrane filter to
sterilize.

iii.	Mucin: Add 0.04 g mucin (from bovine submaxillary gland or
equivalent) to 10 mL of PBS, mix thoroughly until dissolved,
and pass through a 0.2 |im pore diameter membrane, filter,
aliquot, and store frozen at -20±2°C.

iv.	Aseptically aliquot soil stock solutions and store up to one
year at -20±5°C. The stock solutions of the soil load are
single use only; do not refreeze once thawed.

Note: intermittently vortex soil stock solutions while
preparing aliquots. Other volumes of the stock solutions may
be prepared following the same ratio.

g.	Test chemical. Antimicrobial test solution.

h.	Reagent grade sodium hypochlorite (NaOCl) with total chlorine
>4%. To prepare 1,500±150 ppm total chlorine for test system
control.

i.	Tween-80 (polysorbate 80). To make dilution blanks and neutralizers.

j. Laboratory detergent (1% solution). To clean carriers.

4. Apparatus

a.	Carriers: Discs (1 cm in diameter) made of AISI Type 304 Stainless
Steel with 150 grit unidirectional finish on one side. The top of the
carrier is brushed; only the top is visually screened and inoculated.
Carriers are single-use only. See Attachment 1 for complete carrier
specifications and photographs of screened carriers.

b.	Calibrated 10 /iL positive displacement pipette with corresponding
10 |iL tips. For carrier inoculation.

c.	Calibratedmicropipettes (e.g., 200 |iL) with 10-100 or 20-200 |iL
tips. For preparing aliquots of soil and spores; for deposition of test
chemical on carrier.

d.	Bottle-top dispensers, squirt bottles, pre-measured volumes in tubes,
or pipettes. For rinsing vials and filters.

e.	Sterile forceps. To pick up the carriers for placement in vials and to
handle membrane filters.

f.	Filter paper. 150 mm diameter, to line Petri plates.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 6 of 18



g.	Polyethersulfone membrane filter (PES). For recovery of test spores,
47 mm diameter and 0.2 jam pore size. Any filtration apparatus may
be used including filtration units (reusable or disposable).

h.	Vials with lids (plastic or comparable). Sterile, flat-bottomed, wide-
mouthed (at least 25 mm diameter), approximately 20 mL capacity,
for holding inoculated carriers to be exposed to the test chemical and
for accommodating neutralizer.

i.	Vortex mixer. To vortex the fluid in the vials to ensure efficient
recovery of the test organism.

j. Certified timer. Readable in minutes and seconds.

k. Desiccator (with gauge to measure vacuum) with fresh desiccant
(e.g., CaCCte). For drying the inoculum on the carriers.

1. Vacuum source: In-house line or suitable vacuum pump (0.068 to

0.085	MPa) for drying carriers and for membrane filtration.

m. Microscope. With 10X eyepiece and 40X and 100X (oil) objectives
with phase contrast option. To examine spores.

n. Anaerobic chamber. Supported by a gas mixture containing at least
5% Bh with the balance comprised of any inert gas such as CO2, N2,
or Ar; refer to chamber manufacturer's recommendations. Use to
ensure anaerobic environment.

1.	Alternatively, an activated anaerobic jar may be used
according to manufacturer's instructions in place of the
anaerobic chamber.

0. Incubator. Use an incubator at 36±1°C inside an anaerobic chamber
to support the growth of the organism. Alternatively, place the
anaerobic jars in an incubator at 36±1°C.

p. Digital Tit rat or kit. To measure total chlorine and water hardness.
Alternate titration methods may be used.

q. Laboratory film or sterile bags (18 by 30 cm or equivalent). To retain
moisture in plates during prolonged incubation in an anaerobic
chamber.

12. Procedure and
Analysis

1. In brief, the method uses disks (1 cm in diameter) of brushed stainless
steel to represent hard, non-porous surfaces. Each disk receives 10 |iL of
the final test suspension. The final test suspension is dried and exposed to
50 |iL of the test chemical (treated carriers) or 50 |iL of a control fluid
(control carriers). The contact time is allowed to elapse and an appropriate
neutralizer is added at the end of the contact time. The neutralized carriers


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 7 of 18



are vortexed and the resulting suspension is serially diluted and filtered to
determine the presence of spores. Based on mean logio density values, the
LR in the viability of the test organism on treated carriers is calculated in
relation to the viability count on the control carriers.

2. With each efficacy test, three inoculated carriers are exposed to a

treatment consisting of 50 |iL of 1,500±150 ppm NaOCl. The mean LR
(<3.0) in the viability of the spores on test system control carriers ensures
the validity of the data.

12.1 Culture/
Inoculum
Preparation

a. Prepare spores of C. difficile (ATCC 43598) according to MLB SOP

MB-28 (based on ASTM E2839).

i.	Spores may be stored at -80±5°C for up to 90 days prior to
use.

ii.	The mean LD of spores for control carriers is 6.0 to 7.0
spores/carrier, with each control carrier exhibiting a LD of 6.0
to 7.0.

12.2 Preparation
and

sterilization of
carriers

a.	Without magnification, visually check the brushed top surface of the
carriers for abnormalities (e.g., rust, chipping, atypical brushed
striations) and discard if observed; refer to Figures 1 and 2 for
examples of typical acceptable and unacceptable carriers,
respectively.

b.	Soak visually screened carriers in a suitable laboratory detergent
solution free from any antimicrobial activity for 2-4 h to degrease
and then rinse thoroughly in distilled or deionized water. Avoid
extended soaking of the carriers in water or detergent and prolonged
rinsing to reduce risk of corrosion or rusting.

c.	Using gloved hands or forceps, place up to 20 clean dry carriers on a
piece of filter paper inside the bottom surface of a glass Petri dish
(150 mm in diameter), ensure carriers were not damaged (scratched)
during processing.

d.	Cover the Petri dish with its lid and sterilize by autoclaving for 45
min at 121 °C on a gravity cycle.

i.	Alternative validated sterilization cycles may be used to
sterilize carriers.

ii.	Place Petri dish with carriers in autoclave pouch for
sterilization.

e.	Visually inspect carriers to ensure that they are dry following
sterilization.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 8 of 18



f.	After sterilization, aseptically transfer carriers with forceps to sterile
plastic Petri dishes without filter paper for inoculation.

g.	Sterilized carriers may be stored and used for up to six months.1

12.3 Final Test
Suspension
Preparation

a.	Defrost a cryovial of the qualified spore suspension at room
temperature. Each cryovial is single use only.

b.	Vortex the thawed spore suspension for 45-60 s to resuspend the
spores.

c.	Add the spore suspension to the three-part soil load.

i. To obtain 500 [iL of the final test suspension, vortex each

component and combine the following (or appropriate ratio):
25 |iL BSA stock, 35 |iL yeast extract stock, 100 |iL mucin
stock, and 340 |iL spore suspension.

12.4 Carrier

Inoculation

a.	Following the combination of the spore suspension and the soil load,

vortex-mix the final test suspension for approximately 10 s; use

within 30 min for carrier inoculation.

b.	For carrier inoculation:

i.	Withdraw 10 |iL of the final test suspension with a calibrated
positive-displacement pipette (with a 10 |xL pipette tip) and
deposit the final test suspension in the center of each carrier.

ii.	Inoculate a sufficient number of carriers for testing (for
example, ten carriers exposed per test
chemical/concentration/contact time combination, three
exposed to the test system control, three control carriers, plus
extras [for example, three extra carriers]).

iii.	Vortex-mix the final test suspension for approximately 5 s
after inoculating every 5 carriers.

iv.	When inoculating, avoid contact of pipette tip with the
carrier; do not spread the final test suspension with the pipette
tip.

v.	The same pipette tip may be used to inoculate each batch of
carriers. Discard any inoculated carrier where the final test
suspension has run over the edge.

1 Not in ASTM E3218-21.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 9 of 18



c.	Dry the carriers inside a plastic Petri plate (up to 15 carriers/Petri
plate) with the lid off in a biological safety cabinet (BSC) (up to 60
min or until the inoculum is visibly dry).

i.	After the inoculum has dried, place the Petri plate without the
lid in a desiccator connected to a vacuum line.

ii.	Cover the desiccator and make sure that it is properly sealed.
Continue drying the carriers (with the lid off the Petri plate)
under vacuum maintained at 0.068 to 0.085 MPa for 120±5
min at room temperature.

d.	At the end of the drying period, turn off the vacuum, and cover the
plate. Observe the dried inoculum on each carrier. Refer to Fig. 3 for
an example of a typical dried carrier.

i.	Discard any carrier on which the inoculum has dried near the
edge of the carrier or has run off of the surface.

ii.	Use inoculated carriers immediately or store the inoculated
carriers in the desiccator without vacuum. Use dried carriers
within 24 h of inoculation.

12.5 Preparation of
test system
control

a.	Use sterile deionized water as the diluent to prepare 1,500±150 ppm
solution of reagent grade sodium hypochlorite.

b.	Verify the concentration of the prepared NaOCl solution using an
appropriate titration procedure (e.g., Hach digital titrator) prior to use
and use the NaOCl solution within 3 h of preparation.

12.6 Prepare test
chemical

a.	When preparing the test chemical, ensure that the test chemical is
adequately mixed. Use within 3 h of preparation or as specified in the
manufacturer's instructions.

b.	Measuring error increases as delivery volume decreases. To
minimize variability due to measuring error, a minimum of 1.0 mL or
1.0 g of concentrated test chemical should be used when preparing
use-dilutions for testing. Use v/v dilutions for liquid test chemicals
and w/v dilutions for solid test chemicals. Refer to MLB SOP MB-22
for additional information.

c.	Evaluate the test chemical at room temperature (22±2 °C). If
necessary, place test chemical in water bath prior to use to equilibrate
to the appropriate temperature for approximately 10 min. Record
temperature.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 10 of 18

12.7 Efficacy

evaluation -
treated carriers

a.	Using sterile forceps, transfer each dried carrier with the inoculated
side up to a flat-bottom vial and cap the vial. Repeat until all carriers
are transferred.

b.	In a timed fashion at pre-determined staggered intervals, deposit 50
[iL of the test chemical (treatment) over the dried inoculum on the
carriers, ensuring complete coverage of the inoculum.

i.	Use a new tip for each carrier; do not touch the pipette tip to
the carrier surface.

ii.	During testing, do not process carriers where the test
substance runs off of the carrier; replace with new carrier(s)
and vial(s) if this occurs.

iii.	Do not cap the vials.

c.	Hold carriers at 22±2°C for specified contact time.

d.	Within ±3 s of the end of the contact period, add 10 mL of neutralizer
at room temperature to each vial in the specified order according to
the predetermined staggered intervals.

e.	Cap the vial and briefly vortex (2 to 3 s). The neutralized vial is the
10° dilution.

f.	Following the neutralization of the entire set of carriers, vortex each
vial for 30±5 s at high speed to recover the inoculum; ensure that the
carrier is vortexing along with the liquid in the vial.

g.	Visually examine each carrier (that is, look at the carrier through the
bottom of the vial) and, in case of incomplete inoculum removal,
perform further vortexing (for example, 30±5 s) to remove inoculum.
Do not remove the carrier from the vial.

12.8 Dilution and
Recovery

a.	Vortex-mix the vial (10° dilution) for approximately 5 s and prepare
serial ten-fold dilutions in PBS-T as necessary to achieve countable
colonies in the target range of 20 to 200 CFU on the filters. Initiate
dilutions within 30 min of neutralization.

b.	For treated carriers, filter the entire contents of the vial (10° dilution)
through a 0.2 [j,m PES membrane filter; the entire contents of other
dilutions may be filtered as necessary. Initiate filtration within 30
min of preparing the dilutions.

c.	Prior to filtration, pre-wet each membrane filter with approximately
10 mL PBS; apply vacuum to filter the contents. Leave the vacuum
on for the duration of the filtration process.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 11 of 18

i.	To filter the contents of the vial, vortex-mix contents (5 to 10
s) and pour the contents into a filter unit.

ii.	Rinse the vial with approximately 20 mL of PBS, vortex-mix
for approximately 5 s and pour the entire contents of the vial
into the same filter unit. Rinse the inside surface of each filter
unit with an additional approximately 20 mL PBS.

iii.	Gently decant the liquid from the vial into the filter unit,
retaining the carrier in the vial.

iv.	If a carrier falls onto the filter membrane, aseptically remove
it using sterile forceps.

v.	If the filter membrane is compromised (for example,
punctured) by a fallen carrier, discard the filter membrane and
repeat the test chemical exposure using an extra carrier.

d.	To filter the entire contents of dilution tubes, vortex-mix the tube for
approximately 5 s and pour into the filter.

i.	Rinse each tube once with approximately 10 mL of PBS,
vortex-mix for approximately 5 s, and pour the contents of the
tube into the same filter unit.

ii.	Rinse the inside surface of each filter unit with an additional
approximately 20 mL PBS.

e.	Aseptically remove the membrane filters in order (test chemical, test
system control, controls) and place on the pre-reduced BHIY-HT.

i.	Open each sealed package of BHIY-HT plates just prior to
placement of the membrane filter.

ii.	Avoid trapping any air bubbles between the membrane filter
and the agar surface; use sterile forceps to reposition the filter
if necessary.

f.	At the end of the testing, filter approximately 20 mL of the PBS-T
and approximately 20 mL of the PBS used in the test using two
separate membrane filters to assess reagent sterility.

g.	Place BHIY-HT plates with membrane filters under anaerobic
conditions within 60 min of opening the package of plates.

i. Examine the plates immediately prior to use. Do not use
plates showing signs of darkening, bubbles, or other color
abnormalities.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 12 of 18



h.	Incubate BHIY-HT plates with membrane filters under anaerobic
conditions at 36±1°C for 120±4 h.

i.	If using an anaerobic chamber, bag or seal plates with
laboratory film after approximately 24 h of incubation to
minimize moisture loss.

ii.	Bagging or sealing plates with laboratory film immediately
upon incubation inhibits growth of the organism due to the
presence of oxygen absorbed into the agar plate during the
placement of membrane filters.

i.	At the end of the incubation period, count the CFU on each filter.

j. Ensure the sterility of the reagents (PBS-T and PBS). If sterility is
not observed, repeat testing with fresh, sterile reagents.

k. Observe the colony characteristics from at least one of the filters for
purity and typical characteristics of the test microbe.

i.	On white filters, C. difficile colonies appear yellow-brown to
tan.

ii.	On BHIY-HT after 48 to 120 h of incubation, C. difficile
colonies appear circular with an entire edge, convex, smooth
and gray.

iii.	Inspect growth from a typical colony under phase contrast
microscopy. A colony may be comprised of both spores and
vegetative cells: under phase contrast microscopy, spores
appear bright and ovular while vegetative cells appear dark
and rod-shaped.

12.9 Test system
control

a.	Use sterile deionized water as the diluent to prepare a 1500 ±150
ppm solution of reagent grade sodium hypochlorite.

b.	Verify the concentration of the prepared NaOCl solution using an
appropriate titration procedure prior to use and use the NaOCl
solution within 3 h of preparation.

c.	On each test day, expose each of the three carriers to 50 [xL of the
test system control (1500±150 ppm NaOCl) and evaluate as
described in 12.7 through 12.8 using a 3 min ±3 s contact time.

d.	Neutralize test system control carriers with 10 mL PBS-T with 0.1 %
(w/v) sodium thiosulfate.

e.	The test system control must exhibit a mean LR <3.0 spores/carrier
for a valid test.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 13 of 18



f. For test system control carriers, prepare serial dilutions out to 10"5
and filter the entire contents of the 10"3, 10"4, and 10"5 dilution tubes.

12.10 Control carrier
counts

a.	On each test day, expose each of the three control carriers to 50 [xL of
PBS-T and evaluate the carriers as described in 12.7 through 12.8.

i.	Expose control carriers to PBS-T for the same contact time
used for the treated carriers.

ii.	Neutralize control carriers with the same neutralizer used for
the treated carriers.

b.	For control carriers, prepare serial ten-fold dilutions out to 10"5 and
filter the entire contents of the 10"4 and 10"5 dilution tubes.

12.11 Results

a. For all carriers (test chemical treatment, test system control, and
control carrier counts), count the appropriate number of CFU (for
example, up to 200 CFU for filters). Use CFU to calculate log
reduction. Log reduction is used to determine test chemical
effectiveness.

13. Data Analysis/
Calculations

1.	Use values with at least three significant figures when performing
calculations. Report log reduction values with at least two significant
figures.

2.	The logio density (LD) for each treated, test system control, and control
carrier is calculated as follows:

, \\ sun) i..„i

10 ( Ef=1(Ci X Dt) J

where:

Y = CFU per filter,

C = volume filtered,

V= total volume of neutralizer,

D= 10"k,
k = dilution,

n = number of dilutions, and

i = lower limit of summation (the fewest number of dilutions).

3.	Calculate the mean LD for three test system control carriers and three
control carriers as follows:

Mean LD = [Logio(carrier 1) + Logio(carrier 2) + Logio(carrier 3)]/3

4.	Calculate the mean LD for each set of ten treated carriers as follows:
Mean LD = [Logio(carrier 1) + Logio(carrier 2) + Logio(carrier 3) +
Logio(carrier 4) + Logio(carrier 5) + Logio(carrier 6) + Logio(carrier 7) +
Logio(carrier 8) + Logio(carrier 9) + Logio(carrier 10)]/10


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 14 of 18



a. For the purpose of calculation, if no organism is recovered from a
test carrier, the log density for that carrier is 0 provided that the entire
contents of the 10° dilution was filtered.

5.	Calculate the logio reduction (LR) for the test system control:

LR= MeanLD(Control Carriers) -MeanLD(Test System Control Carriers)

6.	Calculate the LR for each test chemical as follows:

LR= MeanLD(Control Carriers) -MeanLD(Treated Carriers)

a. If no organism is recovered from each of the ten test carriers, the log
reduction is greater than or equal to the mean control carrier log
density.

14. Forms and Data
Sheets

1.	Attachment 1: Carrier Specifications

2.	Attachment 2: Neutralizer Verification Test

3.	Test Sheets. Test sheets are stored separately from the SOP under the
following file names:

Physical Screening of Carriers Record Form MB-03 Fl.docx

QM for C.dTest Information Sheet MB-31-07 Fl.docx

QM for C.d.: Time Recording, Dilution and Filtration MB-31-07 F2.docx
Sheet

QM for C.d.: Results Sheet MB-31-07 F3.docx

QM for C.d.: Test Microbe Confirmation Sheet MB-31-07 F4.docx

QM for C.d.: Processing Sheet MB-31-07 F5.docx

QM for C.d. Neutralization Verification Test: Test MB-31-07 F6.docx
Information Sheet

QM for C.d. Neutralization Verification Test: Test MB-31-07 F7.docx
Suspension Preparation Sheet

QM for C.d. Neutralization Verification Test: MB-31-07 F8.docx
Processing Sheet

QM for C.d. Neutralization Verification Test: Time MB-31-07 F9.docx
Recording and Results Sheet

15. References

1. ASTM E3218-21, Standard Test Method for Quantitative Method for
Testing Antimicrobial Agents against Spores of C. difficile on Hard,
Nonporous Surfaces. ASTM International, West Conshohocken, PA,
2021.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 15 of 18

Attachment 1

Carrier Specifications

(AISI Type 304 Stainless Steel Carriers)

General Description: 1 cm non-magnetic disc made of AISI Type 304 Stainless Steel (SS) with
150 grit unidirectional brushed finish on one side.

Material: AISI Type 304 Austensic stainless steel consisting of 18% to 20% Chromium, 8% to
10.5% Nickel, and a maximum of 0.8% Carbon.

•	European Specification X5CrNil8-10 Number 1.4301
Japanese Specification: JIS 4303 SUS 304

Carrier Dimensions:

•	Diameter: 1cm (±0.5 mm)

Stainless Steel Sheet Thickness: 22 gauge; carrier manufacturer will provide thickness of
the original stainless steel sheet (in mm).

Flatness: Carrier height not to exceed 110% of the thickness of the uncut sheet of stainless
steel from which the carriers are manufactured.

Finish: A ground unidirectional finish obtained with 150 grit abrasive (AISI) on the top side of
the stainless steel sheet.

Burr Removal: Remove burrs from the edges of the discs on the bottom side of the carrier using
a manual process.

Passivation: Parts are passivated by the carrier manufacturer according to ASTM A967 in a citric
acid solution and prepared as follows:

Degrease with citrus-based degreaser by soaking in the degrease solution for 1 hour
Rinse with de-ionized water
Passivate by soaking carriers:
o 7%> citric acid solution
o 20-30 min at 35±5°C.

Rinse with de-ionized water

•	Air dry


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 16 of 18

Examples of Physically Screened Carriers"

Fig. 1: Examples of typical acceptable carriers.

Fig. 2: Examples of typical unacceptable carriers.

A	B

Fig. 3: Example of an acceptable (A) and unacceptable inoculated carrier (B).

2 Carriers are screened without magnification.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 17 of 18

Attachment 2

Neutralization Verification Test

1.	Prepare Spore Suspension A (without soil load)

a.	Defrost a cryovial of C. difficile stored at -80±5°C. Vortex the thawed spore
suspension for 45-60 s.

b.	Dilute the spore suspension with PBS-T to achieve an average challenge of 20-200
CFU per 10 |aL (e.g., serially dilute spores through 10"5).

c.	Use Spore Suspension A within 30 min of preparation.

2.	Prepare Final Spore Suspension B (with soil load).

a.	Prepare the soil load: vortex each component for 10 s and combine 25 |oL BSA, 35
|oL yeast extract, 100 |oL of mucin and 340 |oL of Spore Suspension A from dilutions
10"4 and 10"5. Vortex-mix for 10-15 s.

b.	Note: Use two separate serial dilutions of Spore Suspension A (10"4 and 10"5) to
prepare two different concentrations of Final Spore Suspension B to ensure there is at
least one dilution with an average challenge of 20-200 CFU.

3.	Treatments

a.	Neutralizer Effectiveness: Add 50 |aL of the test chemical to each of three reaction
vessels. At timed intervals, add 10 mL of neutralizer to each tube and briefly swirl
(by hand). After 10 s, add 10 |oL of Final Spore Suspension B to each tube and briefly
vortex (5 s). Proceed with section 4.

b.	Neutralizer Toxicity Control. Add 10 mL neutralizer to each of three reaction vessels.
At timed intervals, add 10 |iL of Final Test Suspension B to each tube and briefly
vortex (5 s). Proceed with section 4.

c.	Titer Control. Add 10 mL PBS-T to each of three reaction vessels. At timed intervals,
add 10 |iL of Final Spore Suspension B to each tube and briefly vortex (5 s). Proceed
with section 4.

4.	Processing and Recovery

a.	Hold the mixture for 10±1 min at room temperature (22±2°C). Conduct steps (e.g.,
addition of organism, neutralizer) at timed intervals (e.g., 30 s) to ensure consistent
time of contact.

b.	At the conclusion of the holding period, vortex-mix each tube for 5-10 s and pass the
entire contents of each mixture through a separate, pre-wetted 0.2 |im PES membrane
filter.


-------
SOP No. MB-31-07
Date Revised 09-20-22
Page 18 of 18

c.	Wash each tube with approximately 10 mL PBS and vortex-mix for 5-10 s; filter the
wash through the same filter membrane. Finish the filtration process by rinsing the
inside of the funnel unit with about 20 mL of PBS, filtering the rinsing liquid through
the same filter membrane. Initiate filtration as soon as possible (e.g., within 30 min).

d.	Aseptically remove the membrane with sterile forceps and place it carefully over the
surface of the recovery medium (BHIY-HT). Avoid trapping air bubbles between the
filter and the agar surface. Incubate the plates anaerobically for 120±4 hours at
36±1°C. If using an anaerobic chamber, bag or seal plates with laboratory film after
approximately 24 h of incubation to minimize moisture loss.

5. Acceptance Criteria

a.	The number of CFU in the Titer Control should be in the range of 20-200 CFU/filter.

b.	Calculate the mean CFU per filter for each treatment. For calculations described in
section 5c and 5d below, use a dilution for which the titer control resulted in 20-200
CFU/filter.

c.	The recovered number of CFU in the Neutralizer Effectiveness treatment is at least
50% of the Titer Control; this verifies effective neutralization. A count lower than
50% indicates that the neutralizer is not adequate to inactivate the active ingredient
(test chemical). Counts higher than the Titer Control are also valid.

d.	The recovered number of CFU in the Neutralizer Toxicity Control is at least 50% of
the Titer Control. A count of lower than 50% indicates that the neutralizer is harmful
to the test organism. Counts higher than the Titer Control are also valid.


-------